This signalosome docks at the endosomal membrane and induces activation of the mitogen-activated protein kinase (MAPK) kinase (MEK)–extracellular signal–regulated kinase (ERK) signaling pathway during tumorigenesis, attenuating the development of intestinal cancer. This evidence concerns the gene MAP2K7 and intestinal cancer.